These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32452656)

  • 21. Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis.
    Carneiro A; Baccaglini W; Glina FPA; Kayano PP; Nunes VM; Smaletz O; Bernardo WM; Carvalho IT; Lemos GC
    Int Braz J Urol; 2017; 43(4):588-599. PubMed ID: 27802009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
    Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
    Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
    Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and oncologic findings of extraprostatic extension on needle biopsy in
    Chen JR; Zhao JG; Zhu S; Zhang MN; Chen N; Liu JD; Sun GX; Shen PF; Zeng H
    Asian J Androl; 2020; 22(4):427-431. PubMed ID: 31424026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer.
    Deng T; Zhang J; Meng Y; Zhou Y; Li W
    Medicine (Baltimore); 2018 Sep; 97(38):e12524. PubMed ID: 30235773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancer.
    Kim KH; Han KS; Kim KH; Kim DK; Koo KC; Rha KH; Choi YD; Hong SJ
    Urol Oncol; 2015 Sep; 33(9):383.e17-22. PubMed ID: 26004165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Lactate Dehydrogenase Expression in Different Cancers: A Meta-Analysis.
    Lv J; Zhou Z; Wang J; Yu H; Lu H; Yuan B; Han J; Zhou R; Zhang X; Yang X; Yang H; Li P; Lu Q
    Am J Med Sci; 2019 Dec; 358(6):412-421. PubMed ID: 31813468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer.
    Zhao J; Chen J; Zhang M; Tang X; Sun G; Zhu S; Liu J; Zhang H; Zhang X; Yin X; Zhao P; Zhu X; Ni Y; Dai J; Shen P; Chen N; Zeng H
    Andrology; 2019 Mar; 7(2):184-192. PubMed ID: 30609313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
    Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
    Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.
    Petrelli F; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Barni S
    Acta Oncol; 2015 Jul; 54(7):961-70. PubMed ID: 25984930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
    Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
    Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
    Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
    Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of radical prostatectomy in metastatic prostate cancer: A review.
    Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
    Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma.
    Wang J; Abudurexiti M; Shao N; Wei Y; Zhu Y; Ye DW
    Eur Urol Focus; 2020 Jan; 6(1):53-62. PubMed ID: 30217630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition.
    Liang X; Zhou S; Xiao Z
    Aging (Albany NY); 2023 Sep; 15(17):8770-8781. PubMed ID: 37671944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.
    Löppenberg B; Dalela D; Karabon P; Sood A; Sammon JD; Meyer CP; Sun M; Noldus J; Peabody JO; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Jul; 72(1):14-19. PubMed ID: 27174537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
    Faloppi L; Bianconi M; Giampieri R; Sobrero A; Labianca R; Ferrari D; Barni S; Aitini E; Zaniboni A; Boni C; Caprioni F; Mosconi S; Fanello S; Berardi R; Bittoni A; Andrikou K; Cinquini M; Torri V; Scartozzi M; Cascinu S;
    Oncotarget; 2015 Oct; 6(33):35087-94. PubMed ID: 26397228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.